Replies to post #45174 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

Big pharma stands to lose $B from expiring patents:

http://www.reuters.com/article/us-sanofi-lilly-insulin-idUSBREA0T23620140131

and also from new technology and competition:

http://www.fool.com/investing/general/2013/05/23/the-coming-diabetes-wars.aspx

http://jdrf.org/research/artificial-pancreas/

http://jdrf.org/research/encapsulation/

If 'ya can't beat 'em, then buy 'em.

[$Pistol Pete$]

I think we will hit $1 by 2016 IMO

Go $PMCB

[Richby30]

If all 1.6 billion share are outstanding the buy out offer will not even be close to $1. Maybe, if we are lucky, it will be around .33, and that is considering a lot of things go just right. Please if anyone can give me another example of an OTC biotech ticker with over a billion shares outstanding that was acquired at a premium price to the market trading price, of over $2 per share. I got all year to wait for an example......

[A_realist]

PMCB is heading towards zero. A scenario of a buyout to me is not happening. You seem to have done due dilligence but like most longs have delusional expectations.